Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
04/2012
04/05/2012WO2012042006A1 Imine compounds
04/05/2012WO2012041434A1 Electrolyte formulations containing cyano-alkoxy-borate anions
04/05/2012WO2012040845A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
04/05/2012WO2011160974A3 Statin derivates and intermediates for their production
04/05/2012WO2011139343A3 Amino acid linked peg-lipid conjugates
04/05/2012US20120083642 Ionic liquids, the method for preparing the same and method for removing acetylenes from olefin mixtures using the ionic liquids
04/05/2012US20120083609 Methods for the conversion of a substituted furan to a substituted pyrrole
04/05/2012US20120083500 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x 2/3 antagonists
04/05/2012CA2813189A1 Novel methylcyclohexane derivatives and uses thereof
04/05/2012CA2812154A1 Imine substituted 2, 4 - diaryl - pyrroline derivatives as pesticides
04/05/2012CA2811465A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
04/04/2012EP2435037A1 Hiv protease inhibitors
04/04/2012EP1935881B1 Aryl-substituted nitrogen-containing heterocyclic compound
04/04/2012EP1911743B1 Cyclic amine compound
04/04/2012EP1615878B1 Compounds, compositions and methods of treatment for heart failure
04/04/2012EP1557414B1 Isoquinoline compounds and medicinal use thereof
04/04/2012EP1338336B1 Use of catalysts comprising n-substituted cyclic imides for preparing organic compounds
04/04/2012CN1630510B Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
04/04/2012CN102405211A Proline derivatives as cathepsin inhibitors
04/04/2012CN102405209A Diacylethylenediamine compound
04/04/2012CN102399180A 酸性离子液体催化合成n-苯基马来酰亚胺的方法 Acidic Ionic Liquid Catalyzed Synthesis of n- phenylmaleimide method
04/04/2012CN102399179A 超纯n-甲基吡咯烷酮的生产方法 Ultrapure n- methylpyrrolidone production methods
04/04/2012CN101885697B 一种制备奥拉西坦的方法 A method for preparing oxiracetam
04/03/2012US8148545 Processes for the synthesis of γ nitrocarbonyl and γ dicarbonyl compounds and their pyrrole derivatives
04/03/2012US8148533 Ionic liquids having melting points below about 100 C formed by reaction of a heterocyclic amine with about 2.8 and about 3.2 moles of anhydrous hydrogen fluoride per mole of amine nitrogen. Electrochemical devices having nonaqueous electrolytes containing the ionic liquids are disclosed and sio2 etch
04/03/2012US8148443 Oxonium and sulfonium salts
04/03/2012US8148422 Sulfonamides as TRPM8 modulators
04/03/2012US8148419 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
04/03/2012US8148062 Detection of disease related genes
04/03/2012US8147809 Soft anticholinergic esters
04/03/2012US8147569 Quaternary ammonium salt detergents for use in fuels
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
04/03/2012CA2493329C Releasable polymeric conjugates based on aliphatic biodegradable linkers
03/2012
03/29/2012WO2012039448A1 Asymmetric auxiliary group
03/29/2012WO2012039132A1 Method for producing amino acid amide derivative having fluorine-containing carbamate group, production intermediate thereof, and method for producing ethylene diamine derivative
03/29/2012US20120077988 Branched hetero polyethylene glycol and intermediate
03/29/2012US20120077959 Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate
03/29/2012US20120077779 Inhibitors of Fibroblast Activation Protein Alpha
03/29/2012US20120077752 Composition for improving brain function and method for improving brain function
03/29/2012US20120077711 Novel Ligands and Libraries of Ligands
03/28/2012EP2432762A1 Insecticidal arylpyrrolines
03/28/2012EP2432760A1 Bridged spiro [2.4]heptane derivatives as alx receptor and/or fprl2 agonists
03/28/2012EP1694775B1 Reagent for detecting an analyte
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN102395660A Polyalkylene glycol-based ether pyrrolidone carboxylic acids, and concentrates for the production of synthetic cooling lubricants containing the same
03/28/2012CN102395560A Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
03/28/2012CN102391294A Chiral rare earth complex and preparation method and application thereof
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391168A Symmetrical difunctional coupling agent and coupled molecular imaging agents thereof
03/28/2012CN101838231B A type of pyrrolidine derivative, synthesis method and purposes thereof in synthesizing 2,2'-pyrrolidine
03/28/2012CN101445517B Phosphoramidite monophosphine ligand and preparation method and application thereof
03/27/2012US8143427 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
03/27/2012US8143416 Alternative synthesis of renin inhibitors and intermediates thereof
03/27/2012US8143259 Cold menthol receptor antagonists
03/27/2012CA2698500C Creatine sugar amides and salts thereof
03/27/2012CA2552304C Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof
03/27/2012CA2526991C Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
03/27/2012CA2521784C Reversible pegylated drugs
03/27/2012CA2431487C Oligo or polyalkylene glycol-coupled thrombin inhibitors
03/22/2012WO2012036518A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012WO2012035011A1 Pesticidal arylpyrrolidines
03/22/2012WO2012034957A1 Pesticidal pyrroline n-oxide derivatives
03/22/2012WO2012034688A1 Use of n-substituted 2-pyrrolidone-4-carbonic acid esters as solvents
03/22/2012US20120071670 Method for producing of ultra-clean and high-purity n-methyl pyrrolidone
03/22/2012US20120071664 Beta-amino acids and methods and intermediates for making same
03/22/2012US20120071651 Processes for Preparing 1,2-Substituted Cyclopropyl Derivatives
03/22/2012US20120071640 Sulfurizing reagents and their use for oligonucleotides synthesis
03/22/2012US20120071627 Soluble, Degradable Poly(ethylene glycol) Derivatives for Controllable Release of Bound Molecules into Solution
03/22/2012US20120070856 Cross-linking agents
03/22/2012DE102010046680A1 Verwendung von N-substituierten 2-Pyrrolidon-4-carbonsäureestern als Lösemittel Use of N-substituted 2-pyrrolidone-4-carboxylic acid esters as the solvent
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2430195A2 Compositions and methods for biological sample storage
03/21/2012EP2123636B1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
03/21/2012EP1422218B1 Antiviral agent
03/21/2012EP1248779B1 Glycosidase ihhibitors and preparation thereof
03/21/2012CN102388022A Hydrazide compound and use of the same in pest control
03/21/2012CN102388021A Process for preparing pyrrolidinium salts
03/21/2012CN102382102A Amide compound
03/21/2012CN102382028A Maleimide compound, its preparation and application
03/21/2012CN102382027A Method for preparing levetiracetam
03/21/2012CN101817774B Method for preparing 2-(2-nitrophenyl) pyrrole and 2,5-bis(2-nitrophenyl) pyrrole compounds
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101466694B Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138354 N-substituted pyrrolidonium ionic liquids
03/20/2012US8138220 [2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012CA2504410C Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/15/2012WO2012033736A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012WO2012032479A1 L,5-diaryl-2-alkvlpvrrole-3-substituted nitro esters, selective cox-2 inhibitors and nitric oxide donors
03/15/2012WO2012031383A1 Amide compounds
03/15/2012US20120065408 Synthetic processes for the preparation of aminocyclohexyl ether compounds
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065225 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
03/15/2012US20120065206 Compounds for treating proliferative disorders
03/15/2012US20120065162 N-n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
03/15/2012US20120065103 Prolyl Endopeptidase Probes
03/15/2012US20120065064 Novel herbicides
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 404